Cancer chemotherapy drug wastage in a tertiary care hospital in India—A 3‐month prospective and 1‐year retrospective study
Open Access
- 19 July 2019
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 85 (10) , 2428-2435
Abstract
This study prospectively quantified wastage of cancer chemotherapeutic drugs in an oncology unit to find the associated cost in 3 months. Retrospective analysis of drug usage for 12 months was also conducted to determine the expected drug loss in 1 year. The effect of vial sharing was evaluated under the assumption of sharing. A significant drug wastage of 19.72% (95% confidence interval [CI], 14.52–24.93%) in 3 months and 17.14% (95% CI 14.69–19.59%) in 1 year occurred in our oncology unit. Number of vials purchased (r = 0.362, p < 0.01), weight (r = −0.146, P < .01) and body surface area (r = −0.26, P < .01) correlated with the drug wasted. Vial sharing assumption showed a 9% (95% CI, 2.5–15.5%) reduction in cost in 1 year.Keywords
This publication has 17 references indexed in Scilit:
- A Phamacoeconomic Analysis of Personalized Dosing vs Fixed Dosing of Pembrolizumab in Firstline PD-L1-Positive Non–Small Cell Lung CancerJNCI: Journal of the National Cancer Institute, 2017
- A global comparison of the cost of patented cancer drugs in relation to global differences in wealthOncotarget, 2017
- Adjusting for Drug Wastage in Economic Evaluations of New Therapies for Hematologic Malignancies: A Systematic ReviewJournal of Oncology Practice, 2016
- Overspending driven by oversized single dose vials of cancer drugsBMJ, 2016
- Multiple withdrawals from single-use vials: A study on sterilityInternational Journal of Pharmaceutics, 2015
- Drug waste minimization as an effective strategy of cost-containment in OncologyBMC Health Services Research, 2014
- Oral Chemotherapy Program Improves Adherence and Reduces Medication Wastage and Hospital AdmissionsJournal of the National Comprehensive Cancer Network, 2012
- Determining the optimal vaccine vial size in developing countries: a Monte Carlo simulation approachHealth Care Management Science, 2012
- Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costsBMC Cancer, 2011
- Implications of dose rounding of chemotherapy to the nearest vial sizeSupportive Care in Cancer, 2003